[Sweet's syndrome and erythema nodosum associated with Crohn's disease treated by infliximab].
Vanbiervliet
Geoffroy
G
Anty
Rodolphe
R
Schneider
Stéphane
S
Arab
Kamel
K
Rampal
Patrick
P
Hebuterne
Xavier
X
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004893:Erythema Nodosum / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D016463:Sweet Syndrome / Q000150:complications / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab